XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
RAMAT GAN, ISRAEL, Feb. 27, 2026 (GLOBE NEWSWIRE) — XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) from The